PRODUCT NAME: DAXOTEL INJECTION
GENERIC NAME: DOCETAXEL INJECTION CONCENTRATE IP
MANUFACTURER: FRESENIUS KABI
PACKING: SINGLE DOSE VIAL
ALTERNATIVE NAME: TAXOTERE, DOCEAQUALIP, ZYTAX
USES: Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
WE ARE LEADING SUPPLIER & DISTRIBUTOR OF DAXOTEL INJECTION